n,n-dimethyltryptamine has been researched along with Disease Models, Animal in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 3 (33.33) | 24.3611 |
| 2020's | 2 (22.22) | 2.80 |
| Authors | Studies |
|---|---|
| Borbély, E; Bozsó, Z; Fülöp, L; Penke, B; Schuster, I; Szögi, T; Varga, V | 1 |
| Alpár, A; Frecska, E; Hanics, J; László, M; Merkely, B; Nagy, Z; Nardai, S; Szabó, A; Zahola, P | 1 |
| Bidiga, L; Deak, A; Frecska, E; Ghanem, S; Magyar, Z; Mester, A; Nemes, B; Nemeth, N; Peto, K; Somogyi, V; Tanczos, B | 1 |
| Benson, CJ; Cameron, LP; Dunlap, LE; Olson, DE | 1 |
| Bidiga, L; Deák, Á; Frecska, E; Ghanem, S; Kállay, M; Magyar, Z; Mester, A; Nemes, B; Németh, N; Pető, K; Sógor, V; Tánczos, B | 1 |
| Childress, S; El-Alfy, A; Hamann, MT; Kelly, M; Kochanowska, AJ; Matsumoto, RR; Rao, KV; Stewart, GS; Sufka, KJ | 1 |
| Gillin, JC; Moja, EA; Stoff, DM; Wyatt, RJ | 1 |
| Adams, LM; Geyer, MA | 1 |
| Cannon, E; Gillin, JC; Magyar, R; Schwartz, M; Wyatt, RJ | 1 |
9 other study(ies) available for n,n-dimethyltryptamine and Disease Models, Animal
| Article | Year |
|---|---|
Impact of Two Neuronal Sigma-1 Receptor Modulators, PRE084 and DMT, on Neurogenesis and Neuroinflammation in an Aβ
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Disease Models, Animal; Mice; N,N-Dimethyltryptamine; Neurogenesis; Neuroinflammatory Diseases; Peptide Fragments; Receptors, sigma; Sigma-1 Receptor | 2022 |
N,N-dimethyltryptamine reduces infarct size and improves functional recovery following transient focal brain ischemia in rats.
Topics: Animals; Brain; Brain Ischemia; Disease Models, Animal; Male; Motor Activity; N,N-Dimethyltryptamine; Neuroprotective Agents; Piperazines; Rats; Rats, Wistar; Recovery of Function; Treatment Outcome | 2020 |
Hemorheological and metabolic consequences of renal ischemia-reperfusion and their modulation by N,N-dimethyl-tryptamine on a rat model.
Topics: Animals; Disease Models, Animal; Erythrocyte Deformability; Kidney Diseases; Male; N,N-Dimethyltryptamine; Rats; Reperfusion Injury; Rheology | 2018 |
Effects of N, N-Dimethyltryptamine on Rat Behaviors Relevant to Anxiety and Depression.
Topics: Animals; Anti-Anxiety Agents; Antidepressive Agents; Anxiety Disorders; Conditioning, Psychological; Depressive Disorder; Disease Models, Animal; Exploratory Behavior; Fear; Feeding Behavior; Male; Motor Activity; N,N-Dimethyltryptamine; Rats, Inbred SHR | 2018 |
N,N-dimethyltryptamine Prevents Renal Ischemia-Reperfusion Injury in a Rat Model.
Topics: Animals; Antioxidants; Disease Models, Animal; Kidney; Kidney Transplantation; Male; N,N-Dimethyltryptamine; Rats; Receptors, sigma; Reperfusion Injury; Sigma-1 Receptor | 2019 |
Secondary metabolites from three Florida sponges with antidepressant activity.
Topics: Animals; Anti-Anxiety Agents; Antidepressive Agents; Chickens; Disease Models, Animal; Dose-Response Relationship, Drug; Florida; Hydrocarbons, Brominated; Indole Alkaloids; Marine Biology; Mice; Molecular Structure; N,N-Dimethyltryptamine; Porifera | 2008 |
Disruption of conditioned avoidance behavior by n,n-dimethyltryptamine (DMT) and stereotype by beta-phenylethylamine (PEA): animal models of attentional defects in schizophrenia.
Topics: Animals; Attention; Avoidance Learning; Behavior; Chlorpromazine; Conditioning, Operant; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Tolerance; Haloperidol; Humans; Motor Activity; N,N-Dimethyltryptamine; Pargyline; Phenethylamines; Rats; Schizophrenic Psychology; Stereotyped Behavior; Time Factors; Tryptamines | 1978 |
Effects of DOM and DMT in a proposed animal model of hallucinogenic activity.
Topics: Amphetamines; Animals; Cyproheptadine; Disease Models, Animal; DOM 2,5-Dimethoxy-4-Methylamphetamine; Drug Interactions; Exploratory Behavior; Hallucinogens; Lysergic Acid Diethylamide; Male; N,N-Dimethyltryptamine; Rats; Tryptamines | 1985 |
Failure of N,N-dimethyltryptamine to evoke tolerance in cats.
Topics: Animals; Behavior, Animal; Cats; Disease Models, Animal; Drug Tolerance; Electroencephalography; Hallucinogens; Humans; Lysergic Acid Diethylamide; Male; Motor Activity; N,N-Dimethyltryptamine; Placebos; Psychoses, Substance-Induced; Schizophrenia; Tryptamines; Videotape Recording | 1973 |